Antimicrobial resistance risk assessment in food safety

Journal of Food Protection

Volumn 67, Issue 9, 2004, Pages 2063-2071

  Claycamp, H Gregg ^a   Hooberman, Barry H ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 4444261856     PISSN: 0362028X     EISSN: None     Source Type: Journal    
DOI: 10.4315/0362-028X-67.9.2063     Document Type: Conference Paper

References (53)

1. Ad Hoc Group on Antimicrobial Resistance. 2002. Risk analysis methodology for the potential impact on public health of antimicrobial resistant bacteria of animal origin. Office International des Epizooties, World Organization for Animal Health, Paris.
2. Advisory Committee on Animal Uses of Antimicrobials and Impact of Resistance and Human Health. 2002. Uses of antimicrobials in food animals in Canada: impact on resistance and human health. Veterinary Drugs Directorate, Health Canada, Ottawa.
3. Alliance for the Prudent Use of Antibiotics. 2001. Antibiotic resistance: synthesis of recommendations by expert policy groups. World Health Organization, Geneva.
4. Anonymous. 1994. Addressing emerging infectious disease threats: a prevention strategy for the United States. Centers for Disease Control and Prevention, National Center for Infectious Diseases, Office of Planning and Health Communication, Atlanta, Ga.
5. Anonymous. 2000. Effect of the use of antimicrobial in food-producing animals on pathogen load: systematic review of published literature. Exponent, Alexandria, Va.
6. Anonymous. 2003. National antimicrobial resistance monitoring system: enteric bacteria. Centers for Disease Control and Prevention, Atlanta, Ga. Available at: http://www.cdc.gov/narms/. Accessed 1 May 2003.
7. Bailar, J. C., III, and K. Travers. 2002. Review of assessments of the human health risk associated with the use of antimicrobial agents in agriculture. Clin. Infect. Dis. 34:S135-S143.
8. Barza, M., and K. Travers. 2002. Excess infections due to antimicrobial resistance: the "attributable fraction." Clin. Infect. Dis. 34:S126-S130.
9. Bell, T. A. 2001. Antimicrobial susceptibility data and new animal drug approval in the United States: a historical overview. Aquaculture 196:245-251.
10. Bezoen, A., W. van Haren, and J. C. Hanekamp. 1999. Emergence of a debate: AGPs and public health. Human health and antibiotic growth promoters (AGPs): reassessing the risk. Heidelberg Appeal Netherlands Foundation, Amsterdam.
11. Bonten, M. J. M., R. Willems, and R. A. Weinstein. 2001. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect. Dis. 1:314-325.
12. Brown, M., and M. Stringer. 2002. Microbiological risk assessment in food processing. Woodhead Publishing, Cambridge, UK.
13. Buchanan, R. L., J. L. Smith, and W. Long. 2000. Microbial risk assessment: dose-response relations and risk characterization. Int. J. Food Microbiol. 58:159-172.
14. Claycamp, H. G. 2003. A contemporary approach to risk analysis in GFI #152. Available at: http://www.fda.gov/cvm/index/fdavet/2003/jan-feb03.htm. Accessed 1 May 2003.
15. Codex Alimentarius Committee on Residues of Veterinary Drugs in Foods. 2001. Discussion paper on antimicrobial resistance and the use of antimicrobials in animal production. Food and Agricultural Organization and World Health Organization, Rome.
16. Coleman, M., and H. Marks. 1998. Topics in dose-response modeling. J. Food Prot. 61:1550-1559.
17. Covello, V., and M. Merkhofer. 1993. Risk assessment methods: approaches for assessing health and environmental risks. Plenum Press, New York.
18. Forsythe, S. J. 2002. The microbiological risk assessment of food. Blackwell Publishing, Oxford, UK.
19. Haas, C. N., J. B. Rose, and C. P. Gerba. 1999. Quantitative microbial risk assessment. John Wiley and Sons, New York.
20. Haas, C. N., A. Thayyar-Madabusi, J. B. Rose, and C. P. Gerba. 2000. Development of a dose-response relationship for Escherichia coli O157:H7. Int. J. Food Microbiol. 56:153-159.
21. Hellinger, W. 2000. Confronting the problem of increasing antibiotic resistance. South. Med. J. 93:842-848.
22. Holcomb, D. L., M. A. Smith, G. O. Ware, Y. C. Hung, R. E. Brackett, and M. P. Doyle. 1999. Comparison of six dose-response models for use with food-borne pathogens. Risk Anal. 19:1091-1100.
23. Isaacson, R. E., and M. E. Torrence. 2002. The role of antibiotics in agriculture. American Academy of Microbiology, Washington, D.C.
24. Jacoby, G. A. 1996. Antimicrobial-resistant pathogens in the 1990s. Annu. Rev. Med. 47:169-179.
25. Lammerding, A. M., and A. Fazil. 2000. Hazard identification and exposure assessment for microbial food safety risk assessment. Int. J. Food Microbiol. 58:147-157.
26. Lammerding, A. M., and G. M. Paoli. 1997. Quantitative risk assessment: an emerging tool for emerging foodborne pathogens. Emerg. Infect. Dis. 3:483-487.
27. Leibovici, L., R. Berger, T. Gruenewald, J. Yahav, Y. Yehezkelli, G. Milo, M. Paul, Z. Samra, and S. D. Pitlik. 2001. Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link. J. Antimicrob. Chemother. 48:535-540.
28. Levy, S. B. 1997. Antibiotic resistance: an ecological imbalance, p. 1-14. In D. J. Chadwick and J. Goode (ed.), Antibiotic resistance: origins, evolution, selection and spread. Wiley, Chichester, UK.
29. Levy, S., G. Fitzgerald, and A. Macone. 1976. Spread of antibiotic resistance plasmids from chicken to chicken and from chicken to man. Nature 260:40-42.
30. Linden, P. K. 1998. Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance. Am. J. Med. 104:24S-33S.
31. Marks, H. M., M. E. Coleman, C. T. Lin, and T. Roberts. 1998. Topics in microbial risk assessment: dynamic flow tree process. Risk Anal. 18:309-328.
32. McEwen, S. A., and P. J. Fedorka-Cray. 2002. Antimicrobial use and resistance in animals. Clin. Infect. Dis. 34:S93-S106.
33. McNab, W. B. 1998. A general framework illustrating an approach to quantitative microbial food safety risk assessment. J. Food Prot. 61:1216-1228.
34. National Research Council. 1983. Risk assessment in the federal government: managing the process. National Academy Press, Washington, D.C.
35. National Research Council. 1994. Science and judgment in risk assessment. National Academy Press, Washington, D.C.
36. National Research Council. 1996. Understanding risk: informing decisions in a democratic society. National Academy Press, Washington, D.C.
37. Notermans, S., and A. W. Barendsz. 2002. The evolution of microbiological risk assessment, p. 5-43. In M. Brown and M. Stringer (ed.), Microbiological risk assessment in food processing. CRC Press, Boca Raton, Fla.
38. Notermans, S., and P. Teunis. 1996. Quantitative risk analysis and the production of microbiologically safe food: an introduction. Int. J. Food Microbiol. 30:3-7.
39. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27:887-892.
40. Salisbury, J. G., T. J. Nicholls, A. M. Lammerding, J. Turnidge, and M. J. Nunn. 2002. A risk analysis framework for the long-term management of antibiotic resistance in food-producing animals. Int. J. Antimicrob. Agents 20:153-164.
41. Sanaa, M., N. Bemrah, S. Meyer, O. Cerf, and H. Mohammed. 2000. Quantitative risk assessment related to microbial food contamination. Rev. Epidemiol. Sante Publique 48:11-22.
42. Schwarz, S., C. Kehrenberg, and T. Walsh. 2001. Use of antimicrobial agents in veterinary medicine and food animal production. Int. J. Antimicrob. Agents 17:431-437.
43. Swann, M. M. (chair.). 1969. Report [of the] Joint Committee on the Use of Antibiotics in Animal Husbandry and Veterinary Medicine. Her Majesty's Stationery Office, London.
44. Swartz, M. N. 1994. Hospital-acquired infections: diseases with increasingly limited therapies 1. Proc. Natl. Acad. Sci. USA 91:2420-2427.
45. Swartz, M. N. 2003. Human diseases caused by foodborne pathogens of animal origin. Clin. Infect. Dis. 34:5111-5122.
46. Tollefson, L., and M. Miller. 2000. Antibiotic use in food animals: controlling the human health impact. J. AOAC Int. 83:245-254.
47. Travers, K., and M. Barza. 2002. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin. Infect. Dis. 34:S131-S134.
48. U.S. Food and Drug Administration. 2000. Risk assessment of the public health impact of streptogramin resistance in Enterococcus faecium attributable to the use of streptogramins in animals; request for comments and for scientific data and information. Fed. Regist. 65: 20992-20995.
49. U.S. Food and Drug Administration. 2000. Risk assessment on the human health impact of fluoroquinolone resistant Campylobacter associated with the consumption of chicken. 18 October 2000, revised 5 January 2001. Available at: http://www.fda.gov/cvm/antimicrobial/ risk_asses.htm. Accessed 1 April 2003.
50. U.S. Food and Drug Administration. 2001. Veterinary Medical Advisory Committee: notice of meeting. Fed. Regist. 66:58502-58503.
51. U.S. Food and Drug Administration. 2002. Evaluating the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern. Guidance for Industry 152. Available at: http://www.fda.gov/cvm/guidance/fguide152.doc.
52. U.S. Food and Drug Administration, Food Safety and Inspection Service (FDA/FSIS). 2001. Draft risk assessment of the public health impact of Escherichia coli O157:H7 in ground beef. U.S. Department of Agriculture, Washington, D.C.
53. World Health Organization (WHO). 2001. WHO global strategy for the containment of antimicrobial resistance. Department of Communicable Disease Surveillance and Response, WHO, Geneva.